MedPacto (Korea) Odds of Future Stock Price Finishing Under 7,779

235980 Stock  KRW 4,410  70.00  1.56%   
MedPacto's future price is the expected price of MedPacto instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of MedPacto performance during a given time horizon utilizing its historical volatility. Check out MedPacto Backtesting, MedPacto Valuation, MedPacto Correlation, MedPacto Hype Analysis, MedPacto Volatility, MedPacto History as well as MedPacto Performance.
  
Please specify MedPacto's target price for which you would like MedPacto odds to be computed.

MedPacto Target Price Odds to finish below 7,779

The tendency of MedPacto Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move below current price in 90 days
 4,410 90 days 4,410 
about 9.66
Based on a normal probability distribution, the odds of MedPacto to move below current price in 90 days from now is about 9.66 (This MedPacto probability density function shows the probability of MedPacto Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon MedPacto has a beta of 0.42. This suggests as returns on the market go up, MedPacto average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding MedPacto will be expected to be much smaller as well. Additionally MedPacto has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   MedPacto Price Density   
       Price  

Predictive Modules for MedPacto

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MedPacto. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
4,4064,4104,414
Details
Intrinsic
Valuation
LowRealHigh
4,3384,3414,851
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as MedPacto. Your research has to be compared to or analyzed against MedPacto's peers to derive any actionable benefits. When done correctly, MedPacto's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in MedPacto.

MedPacto Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. MedPacto is not an exception. The market had few large corrections towards the MedPacto's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MedPacto, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MedPacto within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.47
β
Beta against Dow Jones0.42
σ
Overall volatility
709.35
Ir
Information ratio -0.14

MedPacto Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MedPacto for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MedPacto can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
MedPacto generated a negative expected return over the last 90 days
MedPacto has high historical volatility and very poor performance
Net Loss for the year was (17.04 B) with loss before overhead, payroll, taxes, and interest of (1.66 M).
MedPacto has accumulated about 1.29 B in cash with (25.15 B) of positive cash flow from operations.
Roughly 34.0% of the company shares are owned by insiders or employees

MedPacto Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MedPacto Stock often depends not only on the future outlook of the current and potential MedPacto's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MedPacto's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding20.5 M
Cash And Short Term Investments121.6 B
Shares Float13.1 M

MedPacto Technical Analysis

MedPacto's future price can be derived by breaking down and analyzing its technical indicators over time. MedPacto Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of MedPacto. In general, you should focus on analyzing MedPacto Stock price patterns and their correlations with different microeconomic environments and drivers.

MedPacto Predictive Forecast Models

MedPacto's time-series forecasting models is one of many MedPacto's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary MedPacto's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about MedPacto

Checking the ongoing alerts about MedPacto for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for MedPacto help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
MedPacto generated a negative expected return over the last 90 days
MedPacto has high historical volatility and very poor performance
Net Loss for the year was (17.04 B) with loss before overhead, payroll, taxes, and interest of (1.66 M).
MedPacto has accumulated about 1.29 B in cash with (25.15 B) of positive cash flow from operations.
Roughly 34.0% of the company shares are owned by insiders or employees

Other Information on Investing in MedPacto Stock

MedPacto financial ratios help investors to determine whether MedPacto Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MedPacto with respect to the benefits of owning MedPacto security.